About Us

Company Overview

A group of professionals discussing outdoors, with the Bayer logo visible in the background, highlighting a collaborative corporate environment.

Bayer is a life science company and a global leader in healthcare, agriculture and nutrition. Our innovative products are designed to address the challenges of a rapidly growing and aging population. We are helping farmers to produce more while restoring nature, working towards treating the untreatable and curing disease, as well as empowering billions to live healthier lives with trusted self-care solutions.  

Facts and Figures

 

3 Divisions:

Pharmaceuticals, Consumer Health & Crop Science 

 

80+

countries ensuring a strong global presence

 

est. 1863  

building on a strong history

 

94,081 

employees worldwide

 

46.6€bn   

recorded in sales for FY 2024

 

€10.1 bn

(-13.5%) EBITDA in 2024

 

6.2 €bn

invested in research and development in 2024

 

15,900

working in Research & Development

 

42.1%

women in management in 2024

We Are Going All in For the People We Serve

From chronic diseases to agricultural practices, these stories remind us why we are here every day: to help more people live healthier lives and to support those who feed the world. Their voices inspire us at Team Bayer to work with full commitment towards our mission.

A Trusted Brand

Consumers, patients and farmers across the globe associate the Bayer brand with trust, reliability, and quality. The Bayer Cross is recognized as one of the most iconic trademarks in the world and our extensive product portfolio features many world-renowned brands. 

#1

#5

#6

Most valuable global Ag brand in the 2025 Brand Finance Global 500 ranking

Ranked among most valuable global Pharma brands in the 2025 Brand Finance Global ranking

Fortune Global 500 "World´s Most-Admired Companies" in Chemicals Sector

Our Products & Services

Structured in three divisions, we tackle some of the most pressing challenges of our times through our innovative products in agriculture and healthcare:

A female doctor is speaking to a patient in a medical office.

This Division focuses on prescription products, particularly in cardiology and women’s healthcare, as well as speciality therapeutics in oncology, hematology, and ophthalmology. Our radiology business markets advanced diagnostic imaging equipment together with the necessary contrast agents. By combining internal expertise with strategic collaborations, we are advancing the potential of Cell & Gene Therapy (CGT) to address individual health conditions. Our portfolio includes best-selling products such as Xarelto™, Eylea™, Nubeqa™, Mirena™, Adempas™ and Aspirin™ Cardio. 

A mature couple running in nature.

The leading supplier of self-care products, offers a comprehensive portfolio of 150 trusted brands, helping people manage their everyday healthcare needs from immunity support to the treatment of minor ailments. Our best-selling brands include Aspirin™, Bepanthen™, Claritin™ and Elevit™

A female farmer examining wheat plants in a field while holding a tablet. 

As a leader in global agriculture, Crop Science Division delivers a diverse portfolio of solutions that address farming's biggest challenges. Our high-value seeds, leading biotechnology traits, innovative crop protection products, digital tools and our deep research pipeline help farmers produce more while restoring nature. We collaborate with farmers and partners to scale practices that promote economic and environmental sustainability. Key products include PRECEON, Plenexos, Intacta, and Xtendflex. 

Science, Research & Innovation

Our research and innovation efforts are at the heart of our mission to address some of the world's most pressing challenges in health and agriculture. By fostering a culture of scientific excellence and collaboration, we aim to drive breakthroughs that make a real difference.  

Two scientists in lab coats and gloves collaborating on a research project in a laboratory setting.

Our Leadership

Bayer operates under a dual governance system, comprising two key bodies – the Board of Management (6 members, led by Chairman and CEO Bill Anderson) and the Supervisory Board (20 members, chaired by Prof. Dr. Norbert Winkeljohann). This structure ensures effective oversight and strategic direction for the company, promoting transparency and accountability in our operations. 

Meet the team driving our success 

 

Members of the board of management

 

Our Financial Performance

Close-up of hands using a tablet.

The Bayer share is included in nearly all major share indices, is traded on all German stock exchanges, and paid a dividend of €0.11 per share for the 2024 financial year.

Overview of our financial perormance